Cat: IPD-X40138

Recombinant Bacillus amyloliquefaciens Barstar Protein ,His & Myc

  • Price
  • Size
  • Number

    Order now. For delivery time, please consult customer service

  • Pre-sale guidance and worry-free after-sale service
  • Quality assurance for cold chain transportation

Analytical Data

  • 基因名

    Barstar

  • Application

    SPRMSTBLIITCELISA细胞实验药物筛选

  • 别名

    Ribonuclease inhibitor

  • 种属

    Bacillus amyloliquefaciens

  • 表达系统

    E. coli

  • 标签

    N- His & C- Myc

  • 纯度

    Greater than 90% as determined by SDS-PAGE.

  • 蛋白编号

    P11540

  • 表达区间

    2-90aa

  • 分子量

    17.7 kDa

  • 内毒素

    < 1.0 EU per μg protein as determined by the LAL method.

  • 性状

    Freeze-dried powder

  • 缓冲液

    PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.

  • 复溶方法

    Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.

  • 个性化定制

    点位突变 标签定制 buffer定制 全长蛋白定制

  • 稳定性测试

    The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.

  • 保存条件 & 期限

    Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.

  • 运输条件

    In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.

Quality inspection process

Related Products

Protein Description

Barstar is a small, stable protein derived from the bacterium Bacillus amyloliquefaciens, which acts as a specific inhibitor of the ribonuclease barnase. The interaction between Barstar and barnase serves as a classic model for studying protein-protein interactions, folding, and stability, making it a valuable tool in molecular biology. The interest in Barstar has grown due to its potential applications in biotechnology and medicine, including the development of targeted drug delivery systems and the engineering of protein-based therapeutics. Research on Barstar has revealed insights into the mechanisms of protein stability, aggregation, and folding pathways, and efforts to genetically modify Barstar have opened new avenues for improving its binding properties and adaptability to different conditions. Furthermore, Barstar's relatively simple structure and ease of manipulation make it an attractive candidate for use in laboratory studies that aim to better understand the principles of protein function and interaction dynamics. The ongoing exploration of Barstar's capabilities, particularly in the context of protein engineering and synthetic biology, continues to generate significant interest within the scientific community. Thus, understanding and harnessing the properties of Barstar could pave the way for innovative solutions in various fields, including therapeutics, agri-biotechnology, and bioengineering, reflecting the crucial role that this unique protein plays in advancing contemporary biological research and applications.

客服热线

027-8586 6806

E-mail

sales@ipodix.cn

人工客服①

汪经理

18007124176


加微信咨询

人工客服②

简经理

18164034885


加微信咨询
IPODIX North America (HQ)
Proteintech Group, Inc
5500 Pearl Street, Suite 400
Rosemont, IL 60018, USA
1-888-478-4522
proteintech@ptglab.com
IPODIX North America (HQ)
Proteintech Group, Inc
5500 Pearl Street, Suite 400
Rosemont, IL 60018, USA
1-888-478-4522
proteintech@ptglab.com
IPODIX North America (HQ)
Proteintech Group, Inc
5500 Pearl Street, Suite 400
Rosemont, IL 60018, USA
1-888-478-4522
proteintech@ptglab.com
  • 30000+

    Recombinant

  • 100+

    Researcher

  • 100+

    Countries Served

  • ISO

    Certified Quality

Committed to Quality
Driven by Innovation

Learn More About US